XY sold 419,251 shares, closing out a position previously valued at $13.68 million. It represents a 7.21% decrease relative ...
No pharmaceutical stock investor likes it when one of their holdings slices drug prices. This one is reducing the costs of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback